TIAA Trust National Association Sells 344 Shares of STERIS plc (NYSE:STE)

TIAA Trust National Association lowered its stake in STERIS plc (NYSE:STE) by 20.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,360 shares of the medical equipment provider’s stock after selling 344 shares during the quarter. TIAA Trust National Association’s holdings in STERIS were worth $280,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Avalon Trust Co acquired a new stake in STERIS in the 4th quarter worth approximately $30,000. Human Investing LLC bought a new position in shares of STERIS in the fourth quarter valued at approximately $31,000. Anfield Capital Management LLC raised its position in shares of STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 91 shares during the period. Central Pacific Bank Trust Division boosted its holdings in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC boosted its holdings in shares of STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 137 shares during the period. Institutional investors own 94.69% of the company’s stock.

STERIS Stock Down 0.6 %

STE stock opened at $222.99 on Friday. STERIS plc has a twelve month low of $197.82 and a twelve month high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The company has a market cap of $21.91 billion, a PE ratio of 47.34 and a beta of 0.92. The business’s 50-day simple moving average is $222.51 and its 200 day simple moving average is $221.48.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS’s dividend payout ratio is 48.41%.

Analysts Set New Price Targets

A number of research analysts have weighed in on STE shares. Piper Sandler boosted their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. JMP Securities reissued a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Finally, Stephens reaffirmed an “overweight” rating and issued a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, STERIS has an average rating of “Moderate Buy” and an average price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.